Market open · Delayed intraday data · 2:02 PM ET
Last update: Nov 9, 2026, 1:52 PM ET
Hims & Hers Health, Inc.
▼ 6.7% on Oct 30, 2026

Why Hims & Hers Health, Inc. (HIMS) Stock Fell 6.7% on Oct 30, 2026

The clearest new catalyst: Class-action lawsuit deadline notices.

Researched by BestStocks Market Desk · Updated Nov 2, 2026
Prior close
$29.67
Oct 30, 2026 close
$27.68
Change
−$1.99
-6.71%
Rel. volume
1.0×
10.8M shares

Why did HIMS stock fall?

Hims & Hers shares fell 6.7% on October 30, 2026, as multiple law firms (Kessler Topaz Meltzer & Check, Rosen Law Firm, Bragar Eagel & Squire, and Robbins Geller Rudman & Dowd) issued class-action notices ahead of a November 2, 2026 securities fraud lawsuit deadline. The underlying class action targets investors who purchased HIMS securities between August 4, 2025 and July 29, 2026.

  • Class-action lawsuit deadline notices: Multiple law firms issued final notices on October 30–31, 2026 urging investors to join a securities fraud class action before the November 2, 2026 deadline, covering purchases between August 4, 2025 and July 29, 2026.
  • Underlying securities fraud allegations: The class action itself addresses alleged securities fraud during the specified period, though the sources do not detail the specific allegations or triggering event.
Researched from primary and established sources on Nov 2, 2026.

Initial detection

BestStocks first flagged HIMS intraday on Oct 30, 2026; this analysis was finalized after the close using the confirmed −6.7% session move and additional catalyst research.

Show the initial intraday note
Risk-6.7%high confidence

Hims & Hers shares fell 6.40% to $27.77 as multiple law firms (Kaplan Fox, Faruqi & Faruqi, and Kessler Topaz Meltzer & Check) issued class-action notices ahead of a November 2, 2026 securities fraud lawsuit deadline, per newsfilecorp.com and PR Newswire. Volume at 2.92M shares tracked near normal levels for the time of day.

Source: fmp_intraday

What to watch next: November 2, 2026 securities lawsuit deadline and HIMS earnings release (consensus $0.12 EPS).

Other developments that session

News

Securities class action lawsuit against HIMS with November 2, 2026 claim deadline for investors who bought stock August 2025-July 2026.

Source: newsfilecorp.com

Frequently asked questions

Why did Hims & Hers Health, Inc. (HIMS) stock fall on Oct 30, 2026?

Hims & Hers shares fell 6.7% on October 30, 2026, as multiple law firms (Kessler Topaz Meltzer & Check, Rosen Law Firm, Bragar Eagel & Squire, and Robbins Geller Rudman & Dowd) issued class-action notices ahead of a November 2, 2026 securities fraud lawsuit deadline. The underlying class action targets investors who purchased HIMS securities between August 4, 2025 and July 29, 2026.

How much did HIMS stock fall on Oct 30, 2026?

HIMS fell 6.7% during the Oct 30, 2026 trading session.

What were the main drivers behind HIMS's move?

Class-action lawsuit deadline notices; Underlying securities fraud allegations.

This is an archived analysis of HIMS's Oct 30, 2026 session.
See HIMS's latest changes →
Educational research tool — not personalized investment advice. Figures reflect the Oct 30, 2026 session as first analyzed.